- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02853773
Effects of Consuming Artificial Sweeteners and Sugar on Cerebral and Physiological Responses (SUGART)
October 24, 2017 updated by: Luc Tappy, MD, University of Lausanne
Acute Effects of Artificial Sweeteners and Sugar on the Brain Dynamics to Food Image Viewing. An Exploratory, Monocentric, Randomized Controlled Trial in Healthy Young Men
This study aims at investigating the acute influence of artificially sweetened beverages consumption (as compared with sugar-sweetened beverages and water consumption) on brain responses to the viewing of food images, on physiological responses (gut-derived hormones and lipid metabolites) and on the food intake behavior.
Study Overview
Status
Completed
Conditions
Detailed Description
This study is made on a randomized controlled crossover design including three conditions (water, sugar, artificial sweeteners).
Measurements will be performed in fasting and fed conditions.
The test-meal will comprise either an artificially or sugar-sweetened beverage or water (control).
The spatio-temporal brain dynamics to the viewing of food pictures will be assessed by means of electroencephalography (EEG) recordings and electrical neuroimaging analyses.
Venous blood and urine will be collected.
Blood pressure, cardiac frequency and bio-impedance measurements will be performed.
Food intake behavior will be assessed by means of questionnaires and a free-choice buffet.
Each tested condition (water, sugar, artificial sweeteners) will be preceded by a run-in period during which the participants' diet will be controlled (2-day isoenergetic diet).
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1005
- Department of Physiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy
- Caucasian
- Right-handed
- Weak to normal physical activity (< 3hours per week)
- Normal-weight (19<BMI<25 kg/m2)
- Regular consumption of sugar-sweetened beverages (>33cl per week)
Exclusion Criteria:
- Consumption of artificially sweetened beverages exceeding 33cl per week
- Diabetes
- Cardiovascular, kidney, hepatic and/or psychological disorders
- Blood pressure at rest > 140/90mmHg
- Body weight < 50kg
- Hemoglobin < 13.5g/dl
- Ferritin < 50microg/l
- Drug consumption
- Alcohol consumption (>10g/day)
- Smoking
- Any particular diet (e.g. vegetarianism), food allergy and/or intolerance
- Body weight gain or loss of >3kg during the last 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Artificial sweetener
Effects of co-ingestion of artificially sweetened beverage on the response to a test meal
|
participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with artificially sweetened drinks
participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with sugary drinks drinks
|
Active Comparator: Sugar
Effects of co-ingestion of sugar-sweetened beverage on the response to a test meal
|
participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with artificially sweetened drinks
participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with sugary drinks drinks
|
Active Comparator: Water
Effects of co-ingestion of water on the response to a test meal
|
participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with waters
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spatio-temporal brain dynamics
Time Frame: differences observed between 60 min before and 60 min after ingestion of a test meal
|
Spatio-temporal brain dynamics to the viewing of food will be assessed by means of electroencephalography recordings.
|
differences observed between 60 min before and 60 min after ingestion of a test meal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in concentration of blood insulin
Time Frame: -120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal
|
Blood substrate concentration will be measured in fasting conditions and after ingestion of a test meal
|
-120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal
|
Changes in concentration of blood triglyceride
Time Frame: -120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal
|
Blood substrate concentration will be measured in fasting conditions and after ingestion of a test meal
|
-120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal
|
Changes in concentration of blood Fibroblast Growth Factor (FGF)-21
Time Frame: -120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal
|
Blood substrate concentration will be measured in fasting conditions and after ingestion of a test meal
|
-120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal
|
spontaneous food intake
Time Frame: 240 min after ingestion of a test meal
|
Food intake behavior will be assessed by monitoring spontaneous food intake when offered a free-choice buffet.
|
240 min after ingestion of a test meal
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Luc Tappy, Professor, Department of Physiology, University of Lausanne, Switzerland
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2016
Primary Completion (Actual)
September 29, 2017
Study Completion (Actual)
September 29, 2017
Study Registration Dates
First Submitted
February 8, 2016
First Submitted That Met QC Criteria
July 29, 2016
First Posted (Estimate)
August 3, 2016
Study Record Updates
Last Update Posted (Actual)
October 26, 2017
Last Update Submitted That Met QC Criteria
October 24, 2017
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 353/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Subjects
-
Temple UniversityCompleted
-
University Hospital, AngersInstitut de Formation en Education Physique et en Sport d'Angers/Les Ponts...Completed
-
Halia Therapeutics, Inc.TKL Research, Inc.Completed
-
University of California, DavisCompletedNormal SubjectsUnited States
-
Universidade Federal de PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted
-
Madigan Army Medical CenterUnknownNormal SubjectsUnited States
-
Schiefer UlrichCompletedOphthalmologically Normal SubjectsGermany
-
Taiwan Liposome CompanyCompleted
-
Amen Clinics, Inc.CompletedNormal Human SubjectsUnited States
-
Tetraphase Pharmaceuticals, Inc.Completed
Clinical Trials on ingestion of a test meal with sweetener
-
Malaysia Palm Oil BoardUniversity of MalayaCompletedInflammation | Insulin SensitivityMalaysia
-
Swiss Federal Institute of TechnologyUnknownIron-deficiencySwitzerland
-
Isabelle Herter-AeberliKamuzu University of Health Sciences; Wageningen University and Research; Sight...Completed
-
University of PennsylvaniaActive, not recruiting
-
Swiss Federal Institute of TechnologyUnknownIron-deficiencySwitzerland
-
Agroscope Liebefeld-Posieux Research Station ALPUniversity Hospital Inselspital, BerneCompletedInflammation | Obesity | Nutritional InterventionSwitzerland
-
Federico II UniversityCompletedOverweight and ObesityItaly
-
ANTONIOS KOUTELIDAKISDemocritus University of Thrace; University of IoanninaEnrolling by invitation
-
Institut National de Recherche pour l'Agriculture...University of Helsinki; AgroParisTechCompleted
-
University of ChesterCompletedAnemia, Iron-DeficiencyUnited Kingdom